{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:30:21Z","timestamp":1786710621386,"version":"build-2736575974"},"reference-count":25,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"the Ng Teng Fong Healthcare Innovation Programme","award":["NTF_DEC2021_1_C2_CR_01"],"award-info":[{"award-number":["NTF_DEC2021_1_C2_CR_01"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Palliative Medicine"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      The Clinical Frailty Scale (CFS) is widely used, but the \u201cterminally ill\u201d category 9\u2014defined by\n                      <jats:italic toggle=\"yes\">a<\/jats:italic>\n                      &lt;6-month prognosis\u2014may limit nuanced survival estimation in geriatric oncology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>\n                      To evaluate the prognostic utility of the CFS when category 9 is omitted. Methods: This retrospective study analyzed 901 older adults (\u226565 years) with incurable cancer at a palliative clinic. Patients were stratified into CFS 2\u20135 (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 618) and CFS 6\u20138 (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 283). Survival was assessed using multivariate Cox regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Median survival was significantly shorter for CFS 6\u20138 compared to CFS 2\u20135 (90 vs. 158 days;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). For 3-month mortality, CFS 6\u20138 demonstrated a hazard ratio (HR) of 2.25 compared to CFS 2\u20135. After adjusting for age, symptoms, albumin, and comorbidities, the CFS remained an independent predictor of 3-month (HR 2.07) and 6-month mortality (HR 1.57).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Omitting category 9 allows the CFS to provide meaningful prognostic data, facilitating better end-of-life planning in geriatric oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10966218261476769","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T05:43:03Z","timestamp":1786426983000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["The Prognostic Value of the Clinical Frailty Scale Without Category 9 in Older Adults with Advanced Cancer"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1990-2138","authenticated-orcid":false,"given":"Wen Yang","family":"Goh","sequence":"first","affiliation":[{"name":"Department of Palliative Medicine, Tan Tock Seng Hospital, Singapore, Singapore."},{"name":"Palliative Care Centre for Excellence in Research and Education, Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyn Yin Mei","family":"Hum","sequence":"additional","affiliation":[{"name":"Department of Palliative Medicine, Tan Tock Seng Hospital, Singapore, Singapore."},{"name":"Palliative Care Centre for Excellence in Research and Education, Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-025-00320-2"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu210"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.5770\/cgj.23.463"},{"issue":"7","key":"e_1_3_4_5_1","first-page":"1","article-title":"Clinical Frailty Scale versus Geriatric-8 in predicting quality of life among older adults receiving curative cancer treatment","volume":"33","author":"Goh WY","year":"2025","unstructured":"4.Goh WY, , Tan HM, , Teo HL, et al. Clinical Frailty Scale versus Geriatric-8 in predicting quality of life among older adults receiving curative cancer treatment. Support Care Cancer 2025;33(7):1\u20131.","journal-title":"Support Care Cancer"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/imj.16081"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.r490"},{"issue":"2","key":"e_1_3_4_8_1","first-page":"1076","article-title":"Translating Performance Level to Clinical Frailty Scale Category Simplifies Scoring and Indicates Length of Stay and Outcome: A Longitudinal Observational Study","volume":"8","author":"Stow D","year":"2022","unstructured":"7.Stow D, , Frew K, , Paes P, et al. Translating Performance Level to Clinical Frailty Scale Category Simplifies Scoring and Indicates Length of Stay and Outcome: A Longitudinal Observational Study. Gerontol Geriatr Res 2022;8(2):1076.","journal-title":"Gerontol Geriatr Res"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2021.12.009"},{"issue":"1","key":"e_1_3_4_10_1","doi-asserted-by":"crossref","first-page":"e000459","DOI":"10.1136\/bmjonc-2024-000459","article-title":"UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: The TOASTIE study","volume":"3","author":"Baxter MA","year":"2024","unstructured":"9.Baxter MA, , Rowe M, , Zucker K, et al.; NOTCH. UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: The TOASTIE study. BMJ Oncol 2024;3(1):e000459.","journal-title":"BMJ Oncol"},{"issue":"6","key":"e_1_3_4_11_1","first-page":"e13752","article-title":"The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato\u2010oncology inpatients: A cohort study","volume":"31","author":"Welford J","year":"2022","unstructured":"10.Welford J, , Rafferty R, , Hunt K, et al. The Clinical Frailty Scale can indicate prognosis and care requirements on discharge in oncology and haemato\u2010oncology inpatients: A cohort study. Eur J Cancer Care (Engl) 2022;31(6):e13752.","journal-title":"Eur J Cancer Care (Engl)"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2024.101736"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2022.2096594"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-023-04542-w"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.28137"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2021.12.013"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2025.102219"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2012.0556"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12926"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.V48N4p115"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012799"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2020.03.002"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183291"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100384"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2013.04.008"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjconc-2025-000045"}],"container-title":["Journal of Palliative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10966218261476769","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10966218261476769","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10966218261476769","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:34:26Z","timestamp":1786707266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10966218261476769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":25,"alternative-id":["10.1177\/10966218261476769"],"URL":"https:\/\/doi.org\/10.1177\/10966218261476769","relation":{},"ISSN":["1096-6218","1557-7740"],"issn-type":[{"value":"1096-6218","type":"print"},{"value":"1557-7740","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"10966218261476769"}}